Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reconstructing tumor phylogenies from heterogeneous single-cell data.

Gregory Pennington1, Charles A Smith, Stanley Shackney

  • 1Computer Science Department, Carnegie Mellon University, 4400 Fifth Ave., Pittsburgh, PA 15213, USA. gwpenn@gmail.com

Journal of Bioinformatics and Computational Biology
|June 26, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Publisher Correction: Integrated Liquid Biopsy and Tumor Tissue Genomic Profiling of Appendiceal Cancer: cfDNA Burden, Mutation Landscapes, and Clinical Outcomes.

Annals of surgical oncology·2026
Same author

Integrated Liquid Biopsy and Tumor Tissue Genomic Profiling of Appendiceal Cancer: cfDNA Burden, Mutation Landscapes, and Clinical Outcomes.

Annals of surgical oncology·2026
Same author

Deconvolution and phylogeny inference of diverse variant types integrating bulk DNA-seq with single-cell RNA-seq.

Bioinformatics advances·2025
Same author

Intensive Care Unit Monitoring Post-Tonsillectomy in Children with Obstructive Sleep Apnea.

Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale·2025
Same author

Cell-Free DNA, Tumor Molecular Concordance, and Clinical Correlates of Patients with Cancer Treated in a Large Community Health Care Network.

The Journal of molecular diagnostics : JMD·2025
Same author

Biological databases in the age of generative artificial intelligence.

Bioinformatics advances·2025

New computational methods analyze tumor heterogeneity using phylogeny and expectation maximization. This approach identifies distinct cancer subtypes and progression pathways, enabling more accurate prognoses and targeted therapies for breast cancer.

Area of Science:

  • Oncology
  • Computational Biology
  • Genetics

Background:

  • Cancerous tumors with similar clinical symptoms can exhibit significant molecular differences.
  • Distinguishing between genetically distinct cancers is crucial for accurate prognoses and targeted therapies.
  • Characterizing common cancer subtypes and their molecular abnormalities is essential for advancing cancer treatment.

Purpose of the Study:

  • To develop a novel computational method for identifying common tumor progression pathways.
  • To leverage single-cell assays and phylogeny inference to analyze tumor heterogeneity.
  • To combine computational approaches for enhanced accuracy in cancer subtyping.

Main Methods:

  • Application of phylogeny inference algorithms to single-cell assays.

Related Experiment Videos

  • Integration of expectation maximization to infer unknown parameters in phylogeny construction.
  • Development of new algorithms to merge inferred phylogenetic trees across different assays.
  • Validation using simulated data and fluorescent in situ hybridization (FISH) data from breast cancer samples.

    • Main Results:

    • The expectation maximization method was validated on simulated data.
    • The combined approach was demonstrated on breast cancer FISH data.
    • The computational methods showed consistency with previous findings on breast cancer.
    • Novel insights into breast cancer tumor progression mechanisms were provided.

    Conclusions:

    • The developed computational methods accurately identify common tumor progression pathways.
    • The approach enhances the understanding of tumor heterogeneity and molecular abnormalities.
    • This work facilitates more precise cancer prognoses and the development of targeted therapeutics.